B-Cell Leukemia Global Clinical Trials Review, H1, 2016

SKU ID :GD-10191668 | Published Date: 31-May-2016 | No. of pages: 454
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12 Top Five Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of B-Cell Leukemia to Oncology Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of B-Cell Leukemia to Oncology Clinical Trials 17 Clinical Trials by Phase in E7 Countries 18 Clinical Trials in E7 Countries by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Clinical Trials by End Point Status 23 Subjects Recruited Over a Period of Time 24 Clinical Trials by Sponsor Type 25 Prominent Sponsors 26 Top Companies Participating in B-Cell Leukemia Therapeutics Clinical Trials 27 Prominent Drugs 28 Clinical Trial Profile Snapshots 29 Appendix 451 Abbreviations 451 Definitions 451 Research Methodology 452 Secondary Research 452 About GlobalData 453 Contact Us 453 Disclaimer 453 Source 454
List of Tables B-Cell Leukemia Therapeutics, Global, Clinical Trials by Region, 2016* 6 B-Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 B-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 B-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 B-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 B-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 B-Cell Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12 B-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13 Proportion of B-Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2016* 14 B-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 B-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of B-Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2016* 17 B-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 B-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 B-Cell Leukemia Therapeutics, Global, Clinical Trials by Phase, 2016* 20 B-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21 B-Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 B-Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 B-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 B-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25 B-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 B-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 B-Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 List of Figures B-Cell Leukemia Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 B-Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 B-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 B-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 B-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 B-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 B-Cell Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12 B-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13 Proportion of B-Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2016* 14 B-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 B-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of B-Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2016* 17 B-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 B-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 B-Cell Leukemia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20 B-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21 B-Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 B-Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 B-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 B-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25 B-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 B-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 B-Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 GlobalData Methodology 452
F. Hoffmann-La Roche Ltd. Celgene Corporation Novartis AG AbbVie Inc. AstraZeneca Plc GlaxoSmithKline Plc Sanofi Gilead Sciences, Inc. Merck & Co., Inc. Bayer AG
  • PRICE
  • $2500
    $7500

Our Clients